Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes.
The main objective of the present work was to compare the dermal delivery of minoxidil (Mx), a lipophilic drug from ethosomes versus classic liposomes, containing different cholesterol (CHOL) concentrations. All the systems were characterized for shape, lamellarity, particle size and entrapment efficiency percentage (EE), by transmission electron microscopy (TEM), confocal laser scanning microscopy (CLSM), laser diffraction and ultracentrifugation or dialysis methods, respectively. Multilamellar vesicles (MLVs) were obtained and one to six lamellae were visualized by CLSM. The presence of ethanol in the formulations affects the particle size in terms of reducing this parameter. In addition, it was possible to appreciate the influence of CHOL on the vesicle size, because it was increased, as CHOL concentration was higher. When the EE was determined by two different methods (ultracentrifugation and dialysis methods), a clear losing of entrapped drug by the ultracentrifugation method was observed, because the strong energy transmitted to the samples disrupted vesicles. Vesicles were non-occlusively applied on rat skin and the permeation pattern of the different systems, depth into the skin and the main permeation pathway were studied by using beta-carotene as a fluorescent probe. CLSM studies showed that ethosomal systems were much more efficient at delivering the fluorescent substance into the skin in terms of quantity and depth, than either liposomes or hydroalcoholic solutions.
López-Pinto
J M
JM
Department of Pharmaceutical Technology, University of Seville, C/ Prof. García González 2, 41012 Seville, Spain.
González-Rodríguez
M L
ML
Rabasco
A M
AM
D000731:Androstanes / Q000008:administration & dosage*; D000818:Animals; D002626:Chemistry, Pharmaceutical; D002784:Cholesterol / Q000008:administration & dosage*; D004355:Drug Stability; D000431:Ethanol / Q000008:administration & dosage*; D008081:Liposomes; D008914:Minoxidil / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010316:Particle Size; D051381:Rats; D017208:Rats, Wistar; D012869:Skin Absorption
C415601:3-oxo-androstan-17-yl-(2'',2'',6'',6''-tetramethyl-N-oxyl)piperidyl butan-1',4'-dioate; D000731:Androstanes; D008081:Liposomes; D000431:Ethanol; D008914:Minoxidil; D002784:Cholesterol